bupropion has been researched along with Atherogenesis in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Smoking cessation is an important factor in the primary and secondary prevention of cardiac events." | 2.43 | Smoking cessation in patients with coronary artery disease. ( Eisenberg, MJ; Ludvig, J; Miner, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ludvig, J | 1 |
| Miner, B | 1 |
| Eisenberg, MJ | 1 |
1 review available for bupropion and Atherogenesis
| Article | Year |
|---|---|
Smoking cessation in patients with coronary artery disease.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Atherosclerosis; Behavi | 2005 |